Clinical Trial Update: A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of MK-0653H in Japanese adults with hypercholesterolemia has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• MK-0653H

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2018-03-09